Laila Jaragh-Alhadad | Medicinal Chemistry | Best Researcher Award

Published on by Invention Awards

Assist. Prof. Dr. Laila Jaragh-Alhadad | Medicinal Chemistry | Best Researcher Award

Kuwait University, Kuwait

Author Profile

Scopus

Early Academic Pursuits

Assistant Professor Dr. Laila Jaragh-Alhadad began her academic journey in the field of Chemistry, earning her Bachelor’s degree in 2004 and Master’s degree in 2009 from Kuwait University, specializing in Petroleum Chemistry. Her exceptional academic performance and dedication to research earned her a prestigious Ph.D. scholarship from Kuwait University in 2011. She pursued her doctoral studies at Cleveland State University, USA, where she specialized in Clinical Bio-analytical Chemistry and successfully completed her Ph.D. in 2017. Her Ph.D. thesis, titled “Cholesterol conjugated heat shock protein 27 inhibitor as a novel anti-ovarian cancer agent,” reflected her early interest in drug design and medicinal chemistry, focusing on cancer therapeutics.

Professional Endeavors

Dr. Laila Jaragh-Alhadad’s professional career is rooted in excellence and service to science and society. She has been serving as an Assistant Professor in the Department of Chemistry at Kuwait University since 2017. Prior to this, she gained valuable experience as a Chemist at Kuwait’s Environmental Public Authority (2009–2011) and as a Graduate Scientific Assistant at Kuwait University (2006–2008). Her professional endeavors extend to administrative and academic committees, where she has contributed to curriculum design, laboratory safety, student affairs, and applied chemistry coordination. Dr. Alhadad also undertook a sabbatical at the Lerner Research Institute, Cleveland Clinic, USA (2021–2022), further enhancing her expertise in biomedical research and medicinal chemistry applications.

Contributions and Research Focus

Dr. Alhadad’s research focus lies at the intersection of medicinal chemistry, bioanalytical chemistry, and cancer pharmacology. Her pioneering studies involve the synthesis and encapsulation of novel anticancer agents targeting proteins such as HSP27, HER2, and tubulin. She has led several funded research projects at Kuwait University, including investigations into low-density lipoprotein (LDL)-encapsulated anticancer drugs, triazole derivatives, and SIRT2 inhibitors. Her work on targeted drug delivery systems has opened new possibilities for more effective cancer treatments with reduced toxicity. Through her innovative use of in-silico and in-vitro models, Dr. Alhadad has made significant contributions to the advancement of modern medicinal chemistry and drug discovery.

Impact and Influence

The impact and influence of Dr. Laila Jaragh-Alhadad are evident across academic, research, and community platforms. She has actively participated in international conferences in Kuwait, the UK, the USA, Italy, Greece, and China, presenting her cutting-edge research on cancer-targeted therapies. Her commitment to science education and public engagement includes serving on various committees, writing awareness articles on cancer research, and volunteering in scientific and social initiatives. Recognized globally, she has received multiple prestigious awards, including the Best Research Award at the 595th International Conference on Recent Advances in Medical and Health Sciences (Oxford, 2019), and the International Research Award on Oncology and Cancer Research (USA, 2021). Her distinguished teaching award (2020–2021) reflects her excellence in both research and education.

Academic Citations

Dr. Alhadad’s research publications have been highly cited in international journals, demonstrating the broad relevance of her work in medicinal chemistry and cancer therapeutics. Her studies on HSP27 inhibitors and LDL-based drug delivery systems are frequently referenced by other researchers in bio-analytical chemistry and pharmaceutical sciences. The consistent academic citations her work receives underscore her contributions to global scientific knowledge and highlight her position as a respected scholar in the field.

Legacy and Future Contributions

Looking toward the future, Assistant Professor Dr. Laila Jaragh-Alhadad is committed to expanding her research in medicinal chemistry, particularly in the development of targeted therapies for women’s cancers. Her ongoing projects focus on hybrid in-silico/in-vitro drug design and the encapsulation of bioactive compounds for enhanced therapeutic delivery. Through her mentorship, academic leadership, and groundbreaking research, she continues to inspire young scientists and contribute to Kuwait University’s growing reputation for excellence in scientific innovation. Her enduring legacy will be defined by her dedication to advancing medicinal chemistry, improving cancer treatments, and promoting interdisciplinary collaboration across chemistry and biomedical sciences.

Medicinal Chemistry

Assistant Professor Dr. Laila Jaragh-Alhadad’s exceptional research in medicinal chemistry has led to significant advancements in targeted drug delivery and cancer therapeutics. Her pioneering studies on bioactive molecule design, protein inhibition, and encapsulation technologies are transforming the future of medicinal chemistry. Through her leadership, innovation, and global scientific recognition, she continues to shape the evolution of medicinal chemistry toward more effective and personalized cancer treatments.

Featured Publications

Design, synthesis, and antiproliferative activity of antipyrine linked 2-amino-quinoline-3-carbonitrile derivatives as potential dual EGFR/HER-2 inhibitors

Journal: Journal of Molecular Structure

Year: 2026

Citations: 0

A novel one-pot microwave assisted green synthesis of pyridinyl-1,3,5-triazine-2,4-diamine hybrids as potent antimicrobial agents

Journal: BMC Chemistry

Year: 2025

Farrah Liu | Lymphatics | Best Researcher Award

Published on by Invention Awards

Dr. Farrah Liu | Lymphatics | Best Researcher Award

Stanford University , United States

Profile

google scholar

🎓 Early Academic Pursuits

Farrah C. Liu began her academic journey with distinction, graduating as the Valedictorian of Montville Township High School among a class of approximately 350 students. Her early promise was recognized through accolades such as the National Merit Scholarship Award (2012). She continued to excel academically at The College of New Jersey, where she was enrolled in a prestigious 7-year BS/MD program in partnership with Rutgers New Jersey Medical School. During this period, Farrah was honored with Phi Beta Kappa membership and consistently made the Dean’s List, underscoring her intellectual rigor. She broadened her academic horizons with a study abroad program at the Autonomous University of Barcelona in Spring 2015, gaining international perspective and enriching her academic versatility.

🩺 Professional Endeavors

Dr. Liu’s medical training commenced at Rutgers New Jersey Medical School, where she earned her MD in 2019. Her medical education was marked by scholarly excellence, earning her recognition such as the Alpha Omega Alpha Honor Medical Society induction and multiple merit-based scholarships. She began her postgraduate clinical training as a Plastic and Reconstructive Surgery Resident at Stanford University School of Medicine in 2019. Her residency, which spans from 2019 to 2025, places her at the forefront of one of the most competitive and technically demanding specialties in medicine. Dr. Liu’s training is backed by active California medical licensure and DEA certification.

🧪 Contributions and Research Focus

Farrah C. Liu’s contributions to academic medicine began even before her residency. As a Research Fellow at Columbia University Medical Center in 2015, she worked under the mentorship of Dr. Kenneth P. Olive, Ph.D., at the Herbert Irving Comprehensive Cancer Center. Her research interests have remained robust, evidenced by multiple awards recognizing her scientific contributions. These include the Best Paper Award at the 2024 Mount Sinai DIEPDive, and the Stanford Plastic Surgery Thuss Research Award. Her scholarly work has also been featured on the Plastic and Reconstructive Surgery Journal Club Podcast in 2021, an acknowledgment of the clinical relevance and quality of her research.

🌟 Impact and Influence

Farrah’s growing influence in the field of plastic surgery is evident through her numerous leadership and advocacy recognitions. She was named an ASPS Advocacy Summit Future Leader Scholar in 2023 and served as a Stanford Troxel Fellow and a PlastyPAC Leader from 2022 to 2023. She also excelled in national forums, earning the Top Individual Score in the ASPS Residents Bowl (2023). These achievements reflect her ability to synthesize clinical acumen with advocacy and innovation, actively shaping the future of her specialty.

📚 Academic Cites and Recognition

Throughout her career, Dr. Liu has received honors for both research and leadership. She is a recipient of the Alpha Omega Alpha Research Recognition Award (2019), highlighting the academic value of her contributions. Her research poster earned Best Research Poster at the New Jersey Society of Plastic Surgeons Meeting (2018), and her undergraduate and medical studies were supported by multiple scholarships, including the Sylvia and David Schwab Memorial Endowed Scholarship and the Joseph and Marguerite DiSepio Scholarship. Her memberships in honor societies such as Alpha Epsilon Lambda and Phi Beta Kappa further confirm her scholarly achievements.

💻 Technical Skills

Dr. Liu’s work in high-level surgical and academic environments has equipped her with advanced technical and clinical skills, particularly in plastic and reconstructive surgical techniques. Although not explicitly listed, her success in competitive surgical environments and featured podcast articles suggest proficiency in medical writing, surgical planning, data analysis, and potentially research tools such as statistical software, imaging platforms, and academic databases.

👩‍🏫 Teaching and Mentorship Experience

While formal teaching roles are not explicitly listed, Farrah's leadership roles—such as Vice President of Interprofessional Communications in Alpha Epsilon Lambda and her repeated participation in resident summits—suggest active involvement in mentorship, education, and peer training. Her participation in Leadership Education in Advancing Diversity (LEAD) Scholar Program (2022-2023) further supports her role in fostering inclusive learning environments and training the next generation of healthcare professionals.

🧬 Legacy and Future Contributions

Farrah C. Liu’s trajectory reflects a deep commitment to clinical excellence, academic scholarship, and medical leadership. Her work in plastic and reconstructive surgery is likely to influence both clinical practice and future research innovations. With continued dedication, she is poised to become a transformative leader—especially in merging surgical innovation with diversity-focused leadership and patient advocacy. Her legacy will likely span multiple domains: groundbreaking surgical techniques, impactful mentorship, and pioneering research that elevates patient care outcomes.

📚 Selected Publications

Title: Facial fractures as a result of falls in the elderly: concomitant injuries and management strategies
Authors: FC Liu, JN Halsey, NC Oleck, ES Lee, MS Granick
Journal: Craniomaxillofacial Trauma & Reconstruction
Year: 2019

Title: Traumatic falls in the pediatric population: facial fracture patterns observed in a leading cause of childhood injury
Authors: NC Oleck, AA Dobitsch, FC Liu, JN Halsey, TMT Le, IC Hoppe, ES Lee, MS Granick
Journal: Annals of Plastic Surgery
Year: 2019

Title: Sports-related pediatric facial trauma: analysis of facial fracture pattern and concomitant injuries
Authors: AA Dobitsch, NC Oleck, FC Liu, JN Halsey, IC Hoppe, ES Lee, MS Granick
Journal: The Surgery Journal
Year: 2019

Title: Motor vehicle collision injuries: An analysis of facial fractures in the urban pediatric population
Authors: TMT Le, NC Oleck, FC Liu, JN Halsey, IC Hoppe, ES Lee, MS Granick
Journal: Journal of Craniofacial Surgery
Year: 2020

Title: Implications of facial fracture in airway management of the adult population: what is the most effective management strategy?
Authors: TMT Le, NC Oleck, W Khan, JN Halsey, FC Liu, IC Hoppe, ES Lee, MS Granick
Journal: Annals of Plastic Surgery
Year: 2019

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.

 

 

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

Published on by Invention Awards

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

University of Catania, Italy.

Prof. Dr. Antonio Rescifina, born on December 23, 1964, in Messina, Italy, is a distinguished researcher and professor in Organic Chemistry. He currently serves as a Full Professor in the Department of Pharmaceutical Sciences at the University of Catania, where he has been a member of the faculty since 1996. His research focuses on the synthesis of organic compounds with applications in pharmaceuticals, environmental chemistry, and materials science.

Profile

Scopus

Orcid

Education 🎓

Prof. Rescifina holds a degree in Chemistry and Pharmaceutical Technology from the University of Messina (1989), with honors. He later obtained another degree in Pharmacy (1991) and completed a Ph.D. in Chemical Sciences with a specialization in Organic Chemistry from the University of Catania (1995).

Experience 💼

Prof. Rescifina has had an extensive career in research and teaching. He worked as a researcher at the University of Catania and the University of Messina before becoming a professor. Over the years, he has contributed significantly to scientific advancements in organic chemistry, working on numerous projects funded by both national and international organizations. His roles have included being a scientific coordinator of various research projects.

Research Interests 🔬

Organic Chemistry and Pharmaceutical Applications
Dr. Yucra's work primarily focuses on the synthesis of novel chemical compounds for pharmaceutical and industrial applications. His research aims to create more efficient, cost-effective, and sustainable solutions to current challenges in these sectors.

Carbon Dioxide Decarbonization & Valorization
He is committed to developing innovative carbon dioxide decarbonization and valorization processes, which aim to transform CO₂ from a harmful greenhouse gas into valuable industrial products, contributing to environmental sustainability.

Green Chemistry
Dr. Yucra emphasizes green chemistry principles, working on solutions that minimize environmental impact, enhance energy efficiency, and reduce the use of toxic chemicals, all while maintaining effective chemical processes.

Pharmaceutical Nanostructures
In his work on pharmaceutical nanostructures, he explores the development of nanoscale materials that can be used for targeted drug delivery, improving the effectiveness of treatments while reducing side effects.

Supramolecular Catalysis
His interest in supramolecular catalysis focuses on creating catalysts that work through non-covalent interactions, leading to more efficient and selective chemical reactions, with potential applications in pharmaceuticals and green chemistry.

Sustainable Chemistry Materials
Finally, Dr. Yucra is involved in the design and development of innovative materials for sustainable chemistry, aiming to create alternatives to traditional chemical processes that are more sustainable, eco-friendly, and economically viable.

.

Awards 🏆

Prof. Rescifina's work has earned him national recognition, including the prestigious Abilitazione Scientifica Nazionale (National Scientific Qualification) for Full Professor in 2018.

His research contributions have been acknowledged in various funded projects and prestigious conferences.

Selected Publications 📚

Designing a Monolithic Photo-Fenton Catalyst Using a Fungal Hydroxypyrone Metabolic Derivative
Materials Today Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Valentina Giglio, Chiara Zagni, Sabrina Carola Carroccio, Vincenzo Paratore, Guglielmo Guido Condorelli, Giuseppe Floresta, Sandro Dattilo, Antonio Rescifina.

Efficient Green Solvent-Free CO2/Epoxide Cycloaddition Catalyzed by a β-Cyclodextrin-Imidazolium-Based Ionic Liquid
Journal of Industrial and Engineering Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Rita Turnaturi, Sandro Dattilo, Vincenzo Patamia, Giuseppe Floresta, Sabrina Carola Carroccio, Tommaso Mecca, Antonio Rescifina.

A Full Carbon-Based Thermoplastic Photocatalyst for Organic Pollutants Abatement: An Experimental and Computational Study
FlatChem
January 2025 | Journal article
Contributors: Lidia Mezzina, Angelo Nicosia, Vincenzo Patamia, Antonio Rescifina, Luisa D’Urso, Vincenzo Paratore, Placido Giuseppe Mineo.

Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
International Journal of Molecular Sciences
January 20, 2025 | Journal article
Contributors: Rocco Buccheri, Alessandro Coco, Lorella Pasquinucci, Emanuele Amata, Agostino Marrazzo, Antonio Rescifina.

Bio-Based Palladium Catalyst in Cryogel for Cross-Coupling Reactions
Materials Chemistry Frontiers
2024 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Vincenzo Paratore, Guglielmo Guido Condorelli, Sabrina Carola Carroccio, Antonio Rescifina.